These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide. Rodrigues MS, Schaffel R, Assreuy J. Eur J Pharmacol; 1992 Jun 17; 216(3):357-62. PubMed ID: 1330581 [Abstract] [Full Text] [Related]
8. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats. Unger T, Rockhold RW, Schaz K, Vescel P, Bönner G, Rascher W, Ganten D. Clin Sci (Lond); 1979 Dec 17; 57 Suppl 5():157s-160s. PubMed ID: 232020 [Abstract] [Full Text] [Related]
9. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle. Schaffel R, Rodrigues MS, Assreuy J. Can J Physiol Pharmacol; 1991 Jul 17; 69(7):904-8. PubMed ID: 1659490 [Abstract] [Full Text] [Related]
10. Mechanism of the inhibitory actions of some spasmogens on the bradykinin relaxation of the guinea-pig ileum. Hall DW, Bonta IL, Verhoef ER. Eur J Pharmacol; 1974 Mar 17; 25(3):308-15. PubMed ID: 4363949 [No Abstract] [Full Text] [Related]
12. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats. Komori T, Yamamoto K. Jpn J Pharmacol; 1981 Jun 17; 31(3):401-7. PubMed ID: 6273629 [Abstract] [Full Text] [Related]
13. Potentiating effects of bradykinin-related substances on bradykinin-induced contraction of guinea pig ileum and hypotension in rats. Naruse M, Yamanami S, Shuto K, Sakakibara S, Kimura T. Chem Pharm Bull (Tokyo); 1981 Nov 17; 29(11):3369-74. PubMed ID: 7337937 [No Abstract] [Full Text] [Related]
15. Cardiovascular and gastrointestinal effects of bradykinin and its potentiation by thiols in rats. Sherman WT, Gautieri RF. J Pharm Sci; 1969 Aug 17; 58(8):971-5. PubMed ID: 5344532 [No Abstract] [Full Text] [Related]
16. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril. Yamauchi H, Nishimura K, Nakata K, Suda H, Iso T, Shimizu M, Hiramatsu Y. Arzneimittelforschung; 1987 Feb 17; 37(2):157-64. PubMed ID: 3034298 [Abstract] [Full Text] [Related]
17. Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom. Ferreira LA, Möllring T, Lebrun FL, Raida M, Znottka R, Habermehl GG. Toxicon; 1995 Oct 17; 33(10):1313-9. PubMed ID: 8599182 [Abstract] [Full Text] [Related]
19. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats]. Suda H, Yamauchi H, Iso T. Nihon Yakurigaku Zasshi; 1982 Dec 17; 80(6):517-23. PubMed ID: 6298082 [Abstract] [Full Text] [Related]